Stay updated on Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Removal of metadata topics 'Head and neck squamous cell carcinoma' and related terms like 'MedlinePlus Genetics' from the page may affect indexing and search filters, but does not change the trial content or eligibility details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-18T16:26:35.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Adds contextual tags such as 'Head and neck squamous cell carcinoma' and related topic links (MedlinePlus Genetics) and updates revision notes; removes a government funding notice. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-11T11:30:06.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding lapse and NIH Clinical Center operations, and updated the page revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.5%
    Check dated 2026-02-04T07:00:48.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    These are minor UI and metadata updates, including a new 'Show glossary' option, a new 'Last Update Submitted that Met QC Criteria' label, the addition of 'No FEAR Act Data', and the new 'Revision: v3.4.0' tag (with corresponding removals of 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T05:48:04.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:11:18.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a Locations section with Ohio as a study site and updated the revision to v3.3.3. Removed items include HHS Vulnerability Disclosure, Head and neck squamous cell carcinoma, MedlinePlus Genetics, and Ohio Locations.
    Difference
    0.4%
    Check dated 2025-12-23T21:51:12.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial page.